Current challenges in designing GBM trials for immunotherapy.
about
Advances in the treatment of newly diagnosed glioblastomaDendritic cell immunotherapy versus bevacizumab plus irinotecan in recurrent malignant glioma patients: a survival gain analysis.Immunotherapy in glioblastoma: emerging options in precision medicineAn Update on the Role of Immunotherapy and Vaccine Strategies for Primary Brain Tumors.MRI in Glioma Immunotherapy: Evidence, Pitfalls, and Perspectives.Engineering challenges for brain tumor immunotherapy.Detection of immune responses after immunotherapy in glioblastoma using PET and MRI.Primary glioblastoma multiforme tumors and recurrence : Comparative analysis of the danger signals HMGB1, HSP70, and calreticulin.
P2860
Q26773514-C60C107D-CBA8-47AD-990B-1AFE629F5A60Q36201736-907E982B-71C9-41C1-AEE0-A9CBEB6DE00CQ37050960-B7190FCE-EE18-4B2A-B107-EFD9E1D4C422Q38603909-FA1CBE20-22AC-4960-8110-F7585C2AF33DQ39312420-D70DDF5D-A091-4E2A-A573-62DB4EDBA4C9Q39381281-1178CBAC-9D38-4393-9DB7-C098BE1F7C37Q46860353-33D181F2-1B87-4F18-A97D-9763E4D1D0EDQ52145169-A9EC9849-3324-428C-94CF-2828BD36D2C4
P2860
Current challenges in designing GBM trials for immunotherapy.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Current challenges in designing GBM trials for immunotherapy.
@en
type
label
Current challenges in designing GBM trials for immunotherapy.
@en
prefLabel
Current challenges in designing GBM trials for immunotherapy.
@en
P2860
P1476
Current challenges in designing GBM trials for immunotherapy.
@en
P2093
Mark R Gilbert
Shiao-Pei Weathers
P2860
P2888
P304
P356
10.1007/S11060-015-1716-2
P577
2015-01-11T00:00:00Z
P6179
1022270289